Avacta and Integumen team up for detection of novel coronavirus in waste water

Avacta Group plc, the developer of Affimer® biotherapeutics and reagents, is pleased to announce that it has entered into a collaboration with Integumen plc (“Integumen”) to evaluate recently generated Affimer reagents that bind the SARS-COV-2 spike protein for the detection of the coronavirus in wastewater, to provide a real-time alert system to warn of localized COVID-19 outbreaks.

Avacta and Integumen team up for detection of novel coronavirus in waste water
Dr. Alastair Smith

Over 60 percent of COVID-19 positive patients had gastrointestinal symptoms, such as diarrhea, nausea and vomiting, and the SARS-COV-2 virus was found in their fecal samples. Sampling wastewater from households may therefore provide an early warning system for localized outbreaks in communities.

Recently, Avacta announced that it had generated a number of highly specific Affimer reagents that detect the SARS-COV-2 virus spike protein for use in diagnostic tests and in neutralizing therapies.

The collaboration with Integumen announced today aims to evaluate some of these Affimer reagents in next-generation sensors, based on the real-time bacteria detection and alert system1 developed by Rinocloud Ltd, a subsidiary of Integumen, with the aim of integrating these sensors into Modern Water plc’s Microtox water contamination system to detect the coronavirus. The award-winning Microtox system, which can detect the presence of contaminating bacteria, virus and toxins, is distributed by Modern Water and has a global footprint of over 3,000 installations. The proposed Affimer sensors would be consumable items to be replaced on a roughly monthly basis.

Once initial testing of the Affimer reagents is completed over the next few weeks, validation of the sensors will be carried out using SARS-COV-2 virus samples in a containment level 3 laboratory at the University of Aberdeen. Upon successful completion of this evaluation, Integumen and Avacta will enter into a supply agreement to allow Integumen to manufacture and commercialize the wastewater detection sensors globally by retrofitting into Microtox systems.

I am very pleased to be entering into this collaboration with Integumen, which holds substantial commercial potential for an Affimer-based consumable SARS-COV-2 detector unit to retrofit into the globally-installed base of Microtox systems. Affimer reagents are ideal for applications such as this, not only because of their sensitivity and specificity, but also because of their robustness, which is essential when being deployed in real-world situations, such as real-time wastewater analysis.

With the spread of COVID-19 continuing to accelerate globally, we are proud to work with partners like Integumen to provide our Affimer reagents for development on a range of platforms to combat the pandemic. This collaboration has the potential to deliver a product that will play a crucial role in the early detection of COVID-19 hotspots around the world.

I look forward to updating the market very soon on progress with Integumen and our other COVID-19 related programmes.”

Dr. Alastair Smith, Chief Executive of Avacta Group

We are delighted to be collaborating with Avacta, adding their highly specific and robust Affimer reagents to our real-time alert arsenal of pathogen capture devices for the COVID-19 virus in sewage. The global pandemic has highlighted wastewater as a potential early warning hotspot detection opportunity and the inclusion of Affimer reagents adds an established method of capturing the virus to a widely used pathogen alert system."

Gerard Brandon, CEO of Integumen and Chairman of Modern Water plc


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Avacta Life Sciences Ltd.. (2020, July 14). Avacta and Integumen team up for detection of novel coronavirus in waste water. News-Medical. Retrieved on July 22, 2024 from https://www.news-medical.net/news/20200714/Avacta-and-Integumen-team-up-for-detection-of-novel-coronavirus-in-waste-water.aspx.

  • MLA

    Avacta Life Sciences Ltd.. "Avacta and Integumen team up for detection of novel coronavirus in waste water". News-Medical. 22 July 2024. <https://www.news-medical.net/news/20200714/Avacta-and-Integumen-team-up-for-detection-of-novel-coronavirus-in-waste-water.aspx>.

  • Chicago

    Avacta Life Sciences Ltd.. "Avacta and Integumen team up for detection of novel coronavirus in waste water". News-Medical. https://www.news-medical.net/news/20200714/Avacta-and-Integumen-team-up-for-detection-of-novel-coronavirus-in-waste-water.aspx. (accessed July 22, 2024).

  • Harvard

    Avacta Life Sciences Ltd.. 2020. Avacta and Integumen team up for detection of novel coronavirus in waste water. News-Medical, viewed 22 July 2024, https://www.news-medical.net/news/20200714/Avacta-and-Integumen-team-up-for-detection-of-novel-coronavirus-in-waste-water.aspx.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Avacta and Medusa19 enter into a distribution agreement for COVID-19 antigen test